Maryland Prescription Drug Affordability Board

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​The Prescription Drug Affordability Board is an independent unit of state government tasked with protecting Marylanders and the Maryland health care system from the high costs of prescription drug products.​

​​

Section1

Image Grid

​Announcements

​
  • Upcoming: Prescription Drug Affordability Board Meeting on July 28, 2025 at 2:00PM. This meeting will be held in person. Please see the Board page for more information. ​
  • Please visit the Prescription Drug Affordability Board's, Cost Review Study Process page to view the Dossiers for Farxiga and Jardiance, posted on June 18, 2025. ​The PDAB is accepting comments through July 3, 2025.
  • Cost Review Study Process- Request for Information begins​ May 28th, 2025 for Dupixent​ and Skyrizi. Please visit the RFI page for more information concerning submissions and technical assistance. 
  • Join the PDAB Mailing List here​.

Section2

Section3

Quick Links​

​

Section5

Maryland Prescription Drug Affordability Board
16900 Science Drive, Suite 112-114
Bowie, MD 20715
(410) 702-4981